Related Experiment Video
Updated: Apr 16, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
[Anemia in chronic kidney disease--reasons and treatment]
Insights
Anemia affects up to 90% of chronic kidney disease (CKD) patients, increasing cardiovascular risk. Treatment focuses on iron and erythropoiesis-stimulating agents (ESA) after excluding other causes.
Area of Science:
- Nephrology
- Hematology
- Cardiovascular Medicine
Context:
- Anemia is highly prevalent in chronic kidney disease (CKD), affecting up to 90% of patients.
- CKD-related anemia is a significant, non-traditional risk factor for cardiovascular disease in this population.
- Diagnosis involves specific hemoglobin thresholds: <11 g/dL for women and <12 g/dL for men/postmenopausal women.
Purpose:
- To outline the prevalence and significance of anemia in CKD.
- To identify the primary causes of anemia in CKD patients.
- To describe the diagnostic criteria and primary treatment strategies for anemia in CKD.
Summary:
- The main causes of anemia in CKD are iron deficiency and erythropoietin deficiency.
- Differential diagnosis must exclude other potentially reversible causes of anemia.
- Iron supplementation and erythropoiesis-stimulating agents (ESAs) are the cornerstone of CKD anemia management.
Impact:
- Highlights anemia as a critical comorbidity in CKD management.
- Emphasizes the link between CKD anemia and cardiovascular outcomes.
- Provides a concise overview of diagnostic and therapeutic approaches for clinicians.
Abstract:
Anemia in chronic kidney disease (CKD) may affect up to 90% of the patients. It is one of the non typical risk factors of cardiovascular disease, specific for this population. The main reasons of the anemia in CKD are iron and erythropoietin deficiency. It is recognized in women with hemoglobin concentration < 11 g/dl and in men and postmenopausal women with hemoglobin concentration < 12 g/dl. Other potentially reversible reasons of anemia should be excluded in differential diagnosis. Iron and erythropoiesis stimulating agents (ESA) constitute the main treatment of anemia of CKD.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease IV: Nursing Management
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention

